Spark Therapeutics
Spark Therapeutics is a biotechnology company focused on developing gene therapies for rare genetic diseases. It is pioneering one-time treatments targeting inherited retinal disorders, hemophilia, and neurodegenerative conditions using proprietary AAV vector technology. It is a subsidiary of Roche.
Address: 3737 Market Street, Suite 1300, Philadelphia, PA 19104
Phone: 1‑855‑SPARKTX (855) 772‑7589 or (215) 220-9300
-
Here’s How Pennsylvania Can Unlock Its Potential to Become a True Economic Leader
Pennsylvania companies are changing the world. It’s on us to support them and their workers and create opportunities for more to thrive. Spark Therapeutics in…
-
Former CEO Shares Thoughts on How Gov. Shapiro Can Boost PA’s Innovation Economy
Jeff Marrazzo, the former CEO of Philadelphia-based Spark Therapeutics and a member of the innovation subcommittee of Gov. Josh Shapiro’s transition team, has several ideas…
-
Thanks to John Furey of Bryn Mawr Being ‘Hands-On’, Bio-Tech Firm Triples in Size
It seemed the right thing for John Furey to do—take 20 years of experience in different pharma roles, including as COO of Spark Therapeutics, and…
-
Glenolden Property Used as a Research Lab Sold to Spark Therapeutics for $6 Million
A Glenolden property once used as a research laboratory for the University of Pennsylvania has been snatched up by Spark Therapeutics for $6 million, writes…
Founding Partners
Advertisement
Affiliate Partners
Chamber Partners
